Skip to content
Delayed ~15 min

ADCT ADC THERAPEUTICS SA

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Mon 9 Nov 2026 · before market open

What 8 analyst firms say about ADC THERAPEUTICS SA: their latest ratings, price targets and how far the stock is from them. How it works

1.58 USD−0.06 (−3.66%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+137.3%to the avg target 3.75 USD+2.17 USD
Buy 4 · Hold 3 · Sell 0

7 rated views · 8 analyst/firm records · 8 firms

Latest report17 Aug 2026avg report date 23 Jun
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
  • Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD

Recent analyst activity · last 90 days

Our tracked history has 2 reports on ADCT from 2 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 1 has its first observed target in the past year.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Cantor FitzgeraldEric SchmidtBuy23 Mar 2026—
GuggenheimMichael SchmidtBuy17 Aug 20265.00 USD
H.C. WainwrightRobert BurnsHold8 Jun 2026—
JefferiesMaury RaycroftBuy5 Jun 20263.00 USD
RBC Capital MarketsLeonid TimashevHold4 Jun 20262.00 USD
StephensUnnamed analystBuy4 Jun 20265.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
Data feed RESEARCHResearch TeamHold25 Mar 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 07:40 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.